Pfizer Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +4.5% | -6.2% | +0.9% | +2.1% | +4.1% | -5.8% | +4.3% | -1.2% | +5.1% | -6.1% | +1.1% | -4.4% | +0.1% | -20.5% | -2.2% | +4.2% | +13.2% | +24.8% | +30.2% | +27.2% | -0.8% | +7.6% | +8.1% | -18.4% | +7.3% | -23.9% | -31.1% | +5.9% | +8.0% | +2.1% | -10.7% | +33.3% | +0.3% | -22.8% | +6.8% | +13.7% | +5.4% | -17.7% | +4.0% | – | |
| – | +5.5% | -13.2% | +5.7% | +3.3% | +10.8% | -15.0% | +9.7% | -3.9% | +9.4% | -16.3% | +4.0% | +1.6% | -4.7% | -23.2% | -3.4% | +6.5% | +29.2% | +35.4% | +57.0% | +38.4% | -1.6% | +1.1% | -16.0% | -22.9% | +56.0% | -45.4% | -45.6% | +227.6% | -19.0% | -49.0% | +15.0% | +37.5% | -30.8% | -18.9% | +34.6% | -20.3% | +26.4% | -10.3% | -13.5% | – | |
| – | +4.0% | -3.1% | -1.0% | +1.6% | +1.2% | -1.5% | +2.2% | -0.1% | +3.3% | -1.6% | +0.0% | -6.7% | +2.1% | -19.5% | -1.7% | +3.3% | +7.0% | +19.8% | +16.1% | +19.2% | -0.2% | +12.9% | +25.7% | -16.2% | -14.4% | -6.4% | -24.2% | -69.6% | +107.1% | +75.6% | -21.5% | +30.7% | +20.4% | -24.2% | -4.1% | +32.5% | -1.6% | -20.9% | +12.6% | – | |
| – | +33.7% | -32.0% | +4.4% | +4.2% | +24.5% | -24.6% | +3.1% | +11.7% | +22.1% | -30.5% | +8.0% | +24.5% | +23.4% | -40.4% | +23.7% | +10.8% | +45.8% | -40.5% | +12.3% | +19.7% | +120.6% | -61.1% | +22.3% | -4.2% | +34.1% | -31.0% | +6.2% | +1.3% | +3.4% | -10.6% | +7.9% | -4.1% | +17.6% | -27.8% | +12.1% | +61.1% | -13.2% | -23.1% | +6.9% | – | |
| – | +442,200.0% | -25.2% | +3.5% | +2.2% | -58.5% | +135.1% | +3.8% | -1.4% | -74.0% | +268.1% | +5.2% | +95.0% | +0.0% | -98.1% | +71.3% | +1,248.4% | -88.3% | +695.1% | +0.4% | +4.0% | -27.6% | +23.2% | +17.5% | +16.2% | -47.9% | +89.0% | +0.3% | -4.0% | -76.9% | +349.8% | +6.4% | -12.7% | -55.7% | +110.9% | +12.7% | -6.7% | +28.1% | -27.4% | +15.2% | – | |
| – | +27.6% | -27.5% | +3.8% | +2.6% | +28.3% | -24.9% | +3.6% | +3.0% | +17.3% | -21.8% | +6.0% | +3.6% | +27.4% | -40.2% | +11.1% | +5.4% | +42.7% | -33.0% | +7.6% | +7.2% | +82.0% | -51.2% | +18.9% | +3.9% | +35.2% | -27.2% | +23.6% | -18.5% | +22.9% | -18.0% | +7.2% | -8.8% | +24.8% | -28.2% | +12.3% | +52.8% | -3.8% | -33.8% | +9.6% | – | |
| – | -30.7% | +63.0% | -6.7% | +0.2% | -36.0% | +63.0% | +0.4% | -4.1% | -16.5% | +38.2% | -6.6% | -19.8% | -39.3% | +51.9% | -19.1% | -0.4% | -63.2% | +422.4% | +24.5% | +29.4% | -57.7% | +206.2% | +28.9% | -25.1% | -44.9% | +25.0% | -66.1% | -232.5% | – | – | -58.8% | +164.4% | +15.2% | -19.2% | -22.7% | -0.7% | +3.9% | +9.3% | +16.7% | – | |
| – | +2.1% | +4.0% | +1.0% | +2.6% | +2.8% | -5.8% | +5.2% | -4.9% | +19.4% | -2.4% | +7.8% | +5.1% | +1.5% | -6.0% | -5.9% | -6.0% | +0.6% | -3.2% | -6.0% | +2.8% | -3.1% | +2.2% | -9.0% | +6.1% | +0.6% | +1.6% | +59.7% | +36.8% | -0.9% | +14.7% | -1.5% | +0.6% | -5.6% | -11.5% | +0.0% | -0.3% | +9.0% | -6.0% | -0.1% | – | |
| – | -51.6% | +408.5% | -3.4% | -6.0% | -73.4% | +333.1% | +9.7% | -7.7% | -122.6% | – | -4.2% | +159.0% | -114.1% | – | +6.5% | -81.2% | -2.8% | +927.4% | +22.1% | +12.9% | -51.2% | +136.5% | +26.5% | -21.4% | -41.9% | +19.9% | -63.8% | -247.7% | – | – | -103.0% | – | -100.2% | – | +9.3% | +9.5% | -149.3% | – | -120.6% | – | |
| – | -95.1% | +5,764.3% | -10.0% | -1.6% | -1,659.1% | – | +16.5% | -89.8% | -953.0% | – | -311.3% | – | -138.8% | – | +17.5% | -182.2% | – | – | +39.0% | -129.2% | – | +370.7% | +34.0% | -77.3% | -35.4% | +210.9% | -109.9% | – | – | – | -145.7% | – | -279.9% | – | – | -253.2% | – | – | -188.3% | – | |
| – | -41.4% | +303.2% | -1.5% | -7.6% | +332.2% | -71.0% | +8.8% | +6.3% | -109.6% | – | +30.0% | +52.2% | -104.4% | – | +4.0% | -57.9% | -42.3% | +475.8% | +18.9% | +40.7% | -58.4% | +132.0% | +25.4% | -12.6% | -42.1% | +11.0% | -58.0% | -202.9% | – | – | -99.2% | +18,537.5% | -91.0% | +636.2% | -1.9% | +21.7% | -146.5% | – | -109.2% | – | |
| – | -20.3% | +121.7% | -2.0% | -4.1% | -47.8% | +110.2% | +6.8% | -4.9% | -82.5% | +484.9% | -2.7% | +109.5% | -97.7% | +1,411.3% | +4.4% | -53.8% | -5.4% | +260.5% | +18.5% | +10.9% | -43.0% | +94.9% | +22.3% | -18.7% | -32.7% | +14.3% | -47.9% | -126.1% | – | – | -59.6% | +201.6% | -29.1% | -1.7% | +5.3% | +6.1% | -86.6% | +564.2% | -76.1% | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.